A Novel RXR Agonist, UAB30, Inhibits Rhabdomyosarcoma Cells in Vitro

BACKGROUND: While patients with early stage rhabdomyosarcoma (RMS) have seen steady improvement in prognosis over the last fifty years, those with advanced stage or high grade disease continue to have a dismal prognosis. Retinoids have been shown to cause growth suppression and terminal differentiat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Surg Res
Hoofdauteurs: Williams, Adele P., Waters, Alicia M., Stewart, Jerry E., Atigadda, Venkatram R., Mroczek-Musulman, Elizabeth, Muccio, Donald D., Grubbs, Clinton J., Beierle, Elizabeth A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007849/
https://ncbi.nlm.nih.gov/pubmed/29907230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2018.02.057
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items